NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NIH NCI
Contract Value
Not provided
Codes & Classification
Solicitation Number
-
NAICS
-
Classification Code
-
Additional Details
Documents1
The National Cancer Institute (NCI), through its Operations and Technical Support contractor Leidos Biomedical Research, Inc. (Leidos Biomed), has issued a Special Notice regarding a subcontract opportunity for construction services at the Frederick National Laboratory for Cancer Research (FNLCR) in Maryland. This opportunity is being offered under Solicitation H27-1001 and is structured as an Indefinite Delivery/Indefinite Quantity (IDIQ) subcontract, supporting the ongoing mission of the FNLCR.
The primary purpose of this procurement is to secure qualified construction services to support the FNLCR, a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The laboratory plays a critical role in advancing cancer and AIDS research by facilitating the translation of laboratory discoveries into new diagnostic tools and treatments. The construction services sought under this IDIQ subcontract will contribute to maintaining and enhancing the laboratory’s infrastructure, thereby supporting its multi-program research activities and collaborations with university, government, and corporate partners.
The scope of work encompasses a range of construction services required to support the FNLCR’s operational and research needs. While specific project details and deliverables are outlined in the full solicitation (available at the provided URL), contractors should anticipate tasks typical of a research laboratory environment, potentially including facility renovations, upgrades, and new construction to meet evolving scientific requirements.
The contracting entity for this opportunity is the National Institutes of Health (NIH), specifically the NCI, under the Department of Health and Human Services. Leidos Biomed, as the Operations and Technical Support contractor, manages this procurement as part of its Prime Contract No. 75N91019D00024. The place of performance is Maryland, with all work to be conducted within the United States.
Interested parties are directed to obtain the full solicitation and additional information via the FNLCR’s business opportunities webpage (https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/construction-idiq-contract) or by contacting Matthew Hull, Contracts Manager, at [email protected]. For information on other opportunities at FNLCR, a separate link is provided.
It is important to note that this notice is for informational purposes only and does not constitute a request for proposals or offers. The Government will not reimburse any costs incurred in responding to this notice, and any submissions become Government property without the expectation of return or further discussion. Interested contractors are responsible for monitoring the referenced sites for updates or additional opportunities.
This opportunity is classified as a Special Notice and is currently active. Contractors with experience in construction services for research or laboratory environments, and who are interested in supporting the mission of the FNLCR, are encouraged to review the solicitation details and consider this subcontracting opportunity.